Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CHOP with CNS Prophylaxis in Primary Testicular DLBCL
NCT00945724Phase 2Completed
- Sponsor
- International Extranodal Lymphoma Study Group
- Start
- Sep 2009
- Primary completion
- Jun 2019
- Modality
- Targeted Liposomes, Orthosteric Ligands, Stealth (PEGylated) Liposomes
- Countries
- 2
01
Overview
A Phase 2 trial of liposomal cytarabine, methotrexate in primary testicular lymphoma (PTL), sponsored by International Extranodal Lymphoma Study Group. Started Sep 2009; status: completed.
02
Drugs
liposomal cytarabinemethotrexate
03
Conditions
primary testicular lymphoma (PTL)
Beyond the preview
Go deeper on NCT00945724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945724.